Immunotherapy for EWS That early lymphocyte recovery (i.e., an absolute lymphocyte count >500 cells/mL on day 15 of the first course of chemotherapy) is a highly significant independent prognostic indicator for high-risk EWS [ 64 ] suggests that immune reconstitution constitutes a novel direction in EWS management.
1
—
—